載入...
Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
Panitumumab is the first fully human monoclonal antibody to Epidermal Growth Factor Receptor (EGFR) to enter clinical trials for the treatment of solid tumors. The anti-tumor activity of panitumumab has been tested in vitro and in vivo, and inhibition of tumor growth has been observed in numerous ca...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2963923/ https://ncbi.nlm.nih.gov/pubmed/21042543 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|